BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6846970)

  • 1. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of refractory cardiac arrhythmias with amiodarone.
    Leak D; Eydt JN
    Arch Intern Med; 1979 Apr; 139(4):425-8. PubMed ID: 434996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
    Hamer AW; Finerman WB; Peter T; Mandel WJ
    Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
    Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone: value of programmed electrical stimulation and Holter monitoring.
    Fisher JD; Kim SG; Waspe LE; Johnston DR
    Pacing Clin Electrophysiol; 1986 May; 9(3):422-35. PubMed ID: 2423985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.